Latest American Society for Radiation Oncology Stories
ASTRO very pleased by decision to significantly lessen, phase in cuts FAIRFAX, Va., Nov.
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone.
Stereotactic body radiation therapy (SBRT) stopped the growth of cancer at its original site in the lung for three years among nearly 98 percent of patients with early non-small cell lung cancer (NSCLC) who are unable to have the cancer surgically removed.
Men who receive a â€œboostâ€ of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation.
Stereotactic radiosurgery (SRS) offers a less invasive way to eliminate tremors caused by Parkinsonâ€™s disease and essential tremor than deep brain stimulation (DBS) and radiofrequency (RF) treatments, and is as effective.
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients.
Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients.
- An aromatic woolly plant (Origanum dictamnus) native to Crete, formerly believed to have magical powers.